Cargando…

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein

Globally, human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in newborns, young children, and the elderly for which there is no vaccine. The RSV fusion (F) glycoprotein is a major target for vaccine development. Here, we describe a novel monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Qingqing, Wang, Zhao, Ni, Fengyun, Chen, Xiaorui, Ma, Jianpeng, Patel, Nita, Lu, Hanxin, Liu, Ye, Tian, Jing-Hui, Flyer, David, Massare, Michael J., Ellingsworth, Larry, Glenn, Gregory, Smith, Gale, Wang, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366758/ https://www.ncbi.nlm.nih.gov/pubmed/30730999 http://dx.doi.org/10.1371/journal.pone.0210749

Ejemplares similares

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
por: Smith, Gale, et al.
Publicado: (2012)

Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
por: Patel, Nita, et al.
Publicado: (2020)

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
por: Raghunandan, Rama, et al.
Publicado: (2014)

Structural Insights into the Membrane Fusion Mechanism Mediated by Influenza Virus Hemagglutinin
por: Ni, Fengyun, et al.
Publicado: (2014)

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
por: Coleman, Christopher M., et al.
Publicado: (2014)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Tian, Daiyin, et al.
Publicado: (2017)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
por: Fries, Louis, et al.
Publicado: (2017)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
por: Portnoff, Alyse D., et al.
Publicado: (2020)

OPUS-DSD: deep structural disentanglement for cryo-EM single-particle analysis
por: Luo, Zhenwei, et al.
Publicado: (2023)

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
por: Wen, Xiaolin, et al.
Publicado: (2017)

Application of normal-mode refinement to X-ray crystal structures at the lower resolution limit
por: Ni, Fengyun, et al.
Publicado: (2009)

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
por: Mousa, Jarrod J., et al.
Publicado: (2017)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus
por: Liu, Changbao, et al.
Publicado: (2007)

LB19. Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants
por: Fries, Louis, et al.
Publicado: (2018)

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
por: Tang, Aimin, et al.
Publicado: (2019)

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus
por: Ulbrandt, Nancy D., et al.
Publicado: (2008)

Structural basis for broad coronavirus neutralization
por: Sauer, Maximilian M., et al.
Publicado: (2021)

Structural and Functional Studies of Influenza Virus A/H6 Hemagglutinin
por: Ni, Fengyun, et al.
Publicado: (2015)

Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody
por: Feng, Rui, et al.
Publicado: (2021)

Multi-Sensor Fusion by CWT-PARAFAC-IPSO-SVM for Intelligent Mechanical Fault Diagnosis
por: Chen, Hanxin, et al.
Publicado: (2022)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

Basis-neutral Hilbert-space analyzers
por: Martin, Lane, et al.
Publicado: (2017)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
por: Alter, Galit, et al.
Publicado: (2021)

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
por: Logue, James, et al.
Publicado: (2023)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates
por: Triplett, Cheryl A., et al.
Publicado: (2022)

The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein
por: Zhang, Wei, et al.
Publicado: (2019)

Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein
por: Tang, Wei, et al.
Publicado: (2021)

Structural basis for the antibody neutralization of Herpes simplex virus
por: Lee, Cheng-Chung, et al.
Publicado: (2013)

A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex
por: Avanzato, Victoria A., et al.
Publicado: (2019)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

Structural basis of mammalian complex IV inhibition by steroids
por: Di Trani, Justin M., et al.
Publicado: (2022)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort
por: Sande, CJ, et al.
Publicado: (2013)

Molecular Epidemiology and Phylodynamics of the Human Respiratory Syncytial Virus Fusion Protein in Northern Taiwan
por: Chi, Hsin, et al.
Publicado: (2013)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
por: Papenburg, Jesse, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_scmr2aj1elutj9bnbqbr2s0vgv